Learn More
Tocris Bioscience™ UBP 310
GluK1-selective kainate antagonist
Supplier: Tocris Bioscience™ 3621/50
Description
UBP 310 is a GluK1 (formerly GLUK5) kainate receptor antagonist (IC50 = 130 nM); also blocks recombinant homomeric GluK3 (forrmerly GLUK7) receptors. Displays 12,700-fold selectivity for GluK1 (formerly GLUK5) over GluK2 (formerly GLUK6). Exhibits no activity at mGlu group I or NMDA receptors at concentrations of up to 10 μM. Apparent KD value is 18 ± 4 nM for depression of kainate responses on the dorsal root.Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.
Specifications
>98% | |
UBP 310 | |
UBP 310 |
50 mg | |
353.35 |
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
For Research Use Only